Karpouzas George A, Ormseth Sarah R, Ronda Nicoletta, Hernandez Elizabeth, Budoff Matthew J
Division of Rheumatology, Harbor-UCLA Medical Center and Lundquist Institute for Biomedical Innovation, Torrance, CA, USA.
Division of Rheumatology, Harbor-UCLA Medical Center and Lundquist Institute for Biomedical Innovation, Torrance, CA, USA.
J Autoimmun. 2022 May;129:102815. doi: 10.1016/j.jaut.2022.102815. Epub 2022 Mar 30.
To compare coronary plaque burden, proatherogenic cytokines, oxidized low-density lipoprotein (oxLDL), anti-oxLDL antibodies, lipoprotein(a)-cholesterol, and their relationships in patients with rheumatoid arthritis with low-density lipoprotein cholesterol (LDL-C)<1.8 mmol/L versus ≥1.8 mmol/L. Also, to study differences in inflammation and proprotein convertase subtilisin/kexin type-9 (PCSK9), which impacts LDL clearance, in patients with low versus high LDL-C.
Computed tomography angiography evaluated coronary plaque (noncalcified, partially calcified, fully calcified, and high-risk plaque) in 150 patients from a single-center observational cohort. Ox-LDL, anti-oxLDL IgG, lipoprotein(a)-cholesterol, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), interleukin-6, tumor necrosis factor-α (TNF-α) and PCSK9 were measured. Analyses adjusted for Framingham general cardiovascular risk score, statin use, and high-density lipoprotein cholesterol.
Patients with LDL-C<1.8 mmol/L versus ≥1.8 mmol/L demonstrated: 1) higher likelihood of per-segment plaque (adjusted-OR = 1.67 [95%CI = 1.10-2.55], p = 0.017) and high-risk plaque presence (adjusted-OR 2.78 [95%CI = 1.06-7.29], p = 0.038); 2) greater anti-oxLDL titers (p = 0.020), which positively associated with TNF-α and likelihood of noncalcified, partially calcified and high-risk plaque presence only in patients with LDL-C<1.8 mmol/L (all p-for-interaction≤0.046); 3) increased lipoprotein(a)-cholesterol content (10.33% [8.11-12.54] versus 6.68% [6.10-7.25], p < 0.001), which positively associated with oxLDL (p < 0.001) and anti-oxLDL (p = 0.036); 4) higher interleukin-6 and PCSK9. No differences in CRP, ESR, or oxLDL were observed.
RA patients with LDL-C<1.8 mmol/L had more coronary plaque, higher anti-oxLDL titers and anti-oxLDL associated with plaque only in this group. It is possible the observed paradoxical association of low LDL-C with greater atherosclerosis may be related to higher production of the oxidation-prone lipoprotein(a)-cholesterol and anti-oxLDL antibodies, resulting in increased vascular LDL uptake and plaque formation.
比较低密度脂蛋白胆固醇(LDL-C)<1.8 mmol/L与≥1.8 mmol/L的类风湿关节炎患者的冠状动脉斑块负荷、促动脉粥样硬化细胞因子、氧化型低密度脂蛋白(oxLDL)、抗oxLDL抗体、脂蛋白(a)-胆固醇及其相互关系。此外,研究LDL-C水平低与高的患者在炎症和影响LDL清除的前蛋白转化酶枯草溶菌素/克新9型(PCSK9)方面的差异。
通过计算机断层扫描血管造影术评估来自单中心观察性队列的150例患者的冠状动脉斑块(非钙化、部分钙化、完全钙化和高危斑块)。检测ox-LDL、抗oxLDL IgG、脂蛋白(a)-胆固醇、C反应蛋白(CRP)、红细胞沉降率(ESR)、白细胞介素-6、肿瘤坏死因子-α(TNF-α)和PCSK9。分析对弗雷明汉一般心血管风险评分、他汀类药物使用和高密度脂蛋白胆固醇进行了校正。
LDL-C<1.8 mmol/L与≥1.8 mmol/L的患者相比:1)每段斑块的发生可能性更高(校正比值比=1.67 [95%置信区间=1.10-2.55],p=0.017)以及高危斑块的存在可能性更高(校正比值比2.78 [95%置信区间=1.06-7.29],p=0.038);2)抗oxLDL滴度更高(p=0.020),仅在LDL-C<1.8 mmol/L的患者中,抗oxLDL滴度与TNF-α以及非钙化、部分钙化和高危斑块的存在可能性呈正相关(所有交互作用p值≤0.046);3)脂蛋白(a)-胆固醇含量增加(10.33% [8.11-12.54] 对6.68% [6.10-7.25],p<0.001),其与oxLDL(p<0.001)和抗oxLDL(p=0.036)呈正相关;4)白细胞介素-6和PCSK9更高。未观察到CRP、ESR或oxLDL的差异。
LDL-C<1.8 mmol/L的类风湿关节炎患者有更多的冠状动脉斑块、更高的抗oxLDL滴度,且仅在该组中抗oxLDL与斑块相关。观察到的低LDL-C与更严重动脉粥样硬化之间的矛盾关联可能与易氧化的脂蛋白(a)-胆固醇和抗oxLDL抗体的产生增加有关,从而导致血管LDL摄取增加和斑块形成。